White House Asks Congress to Get Moving on COVID-19 Relief Funding
The Biden administration released another statement on Wednesday reminding lawmakers of the consequences of not resolving the issue quickly.
The Biden administration released another statement on Wednesday reminding lawmakers of the consequences of not resolving the issue quickly.
Assay tech company shares that its Q1 2022 results were better than expected in spite of declines in COVID-19 product sales.
False and fraudulent claims, particularly those relating to COVID-19 and telemedicine, made up most of the key enforcement actions announced by the DOJ this past week
On April 14, the FDA announced that, for the first time, it has granted Emergency Use Authorization for a COVID-19 breathalyzer test.
A recent AMP report offers recommendations to policymakers to prevent problems in future public health emergencies.